UK markets closed

Alzamend Neuro, Inc. (ALZN)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.0604-0.0096 (-0.90%)
At close: 03:58PM EST
1.0534 -0.01 (-0.66%)
After hours: 04:54PM EST
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/04/2022
30/04/2021
30/04/2020
30/04/2019
Total revenue
0
0
0
0
0
Operating expenses
Research development
5,661
5,201
1,311
1,069
3,700
Selling general and administrative
7,388
7,118
3,641
3,355
1,309
Total operating expenses
13,049
12,320
4,952
4,424
5,009
Operating income or loss
-13,049
-12,320
-4,952
-4,424
-5,009
Interest expense
34.428
46.524
158.803
-
-
Total other income/expenses net
-
4
62.418
-
-
Income before tax
-13,079
-12,362
-5,047
-4,410
-4,862
Income from continuing operations
-13,079
-12,362
-5,047
-4,410
-4,862
Net income
-13,079
-12,362
-5,047
-4,410
-4,862
Net income available to common shareholders
-13,079
-12,362
-5,047
-4,410
-4,862
Basic EPS
-
-0.14
-0.06
-0.05
-0.05
Diluted EPS
-
-0.14
-0.06
-0.05
-0.05
Basic average shares
-
89,095
84,930
88,754
88,754
Diluted average shares
-
89,095
84,930
88,754
88,754
EBITDA
-
-12,312
-4,888
-4,424
-5,009